Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Enfamil LIPIL

This article was originally published in The Tan Sheet

Executive Summary

Mead Johnson's DHA-, ARA-fortified infant formula is now available, BMS subsidiary announces March 7. Labeling states formula "provides a blend of DHA and ARA nutrients found in breast milk [which] are important building blocks for a baby's brain and eyes. Closest formula to breast milk ever." 32-oz ready-to-use liquid sells for about $5.69...

You may also be interested in...

U.S. Formula Industry Poorly Conveys Breast Milk Benefits – WHO Report

Infant formula labeling does not adequately warn consumers about the potential health problems and consequences associated with formula use, according to a recent report

Colgate Was Drawn To Hello Products’ Youthful Lifestyle Branding; Now It Just Launched A CBD Line

Successfully acquired by Colgate-Palmolive on 31 January, Hello quickly made a statement with the launch of a CBD oral-care range and its first go at lip care, CBD Vegan Lip Balm. Available exclusively through Ulta Beauty, the CBD products have the potential to score well with younger consumers interested in natural ingredients, eco-friendly packaging and, of course, cannabis-based innovations.

Bluebird Expects Three Filings In 2020, But US Zynteglo Submission Pushed Back

A BLA filing for Zynteglo in beta-thalassemia is expected in the second half of 2020 instead of the first half, but the first commercial patient in the EU will be treated in the first half of this year.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts